China Medicine Corp. China Medicine Corp.

China Medicine Corp.

CHME

Rank in Stocks #32456
China Medicine Corporation produces and distributes prescription and over the... China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.
Share Price
$0.021
Last synced: 2026-11-12
Market Cap
$1.53M
Change (1 day)
0.00%
Change (1 year)
-47.50%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for China Medicine Corp. (CHME)
EPS as of June 2026 TTM: 0.00
According to China Medicine Corp.'s latest financial reports, its current EPS (TTM) is 0.00. At the end of 2025 the company had an EPS of 0.00, a decrease compared to its 2009 EPS of $0.11.
EPS history for China Medicine Corp. from 2004 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) 0.00 -100.00%
2025 0.00 -100.00%
2009 $0.11 -81.67%
2008 $0.60 7.14%
2007 $0.56 -13.85%
2006 $0.65 -13,100.00%
2005 $-0.01 -101.22%
2004 $0.41 0.00%
EPS for similar companies or competitors

Questions about China Medicine Corp.'s earnings per share (EPS)

What was China Medicine Corp.'s earnings per share (EPS) in 2025?

In 2025, China Medicine Corp.'s earnings per share (EPS) was 0.00, compared with $0.11 in 2009.

How does China Medicine Corp.'s earnings per share (EPS) compare with similar companies?

China Medicine Corp.'s earnings per share (EPS) (0.00) is lower than that of all 5 similar companies listed above. The highest among them is Ipsen S.A., with $6.83.